⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9298907 | 0.68 | KDM4E (0.37) | — | |
| SCHEMBL14801283 | 0.65 | ALDH1A1 (0.47) | — | |
| Sulfuric Acid SCHEMBL5497691 | 0.60 | SMPD3 (0.33) | — | |
| SCHEMBL4248517 | 0.56 | HCAR3 (0.42) | — | |
| SCHEMBL21893443 | 0.55 | LPO (0.40) | — | |
| SCHEMBL16370745 | 0.55 | KDM4E (0.44) | — | |
| SCHEMBL7825017 | 0.54 | ALDH1A1 (0.34) | — | |
| SCHEMBL21241215 | 0.54 | MAPK1 (0.49) | — | |
| SCHEMBL43654 | 0.54 | ALDH1A1 (0.38) | — | |
| SCHEMBL20540314 | 0.53 | MEN1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1556389-B9 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-1556389-B3 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2015-04-01 | — | — | EP | disclosed |
| EP-1556389-B1 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2007-07-25 | — | — | EP | disclosed |
| US-20070037786-A1 | Cephem compounds | WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-7129232-B2 | For therapy of of infectious diseases | ASTELLAS PHARMA INC. (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20040132994-A1 | Cephem compounds | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2004-07-08 | — | — | US | disclosed |